BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, June 3, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 25, 2010
View Archived Issues
Sorafenib exhibits antitumor activity in hematological malignancies in phase I trial
Read More
S1RA shows promise as analgesic for neuropathic pain
Read More
Merck & Co. claims new angiotensin AT receptor antagonists
Read More
VIA Pharmaceuticals discloses new DGAT inhibitors
Read More
Organon discovers new cannabinoid CB2 receptor agonists
Read More
New B-raf kinase inhibitors claimed by Korean scientists
Read More
Otsuka identifies new quinolone compounds for Parkinson's disease
Read More
Temsirolimus is safe in children with neuroblastoma, high-grade glioma and rhabdomyosarcoma
Read More
CYP3A4 inducers and presence of food affect lurasidone exposure
Read More
Genentech suspends development of MTRX-1011A in rheumatoid arthritis
Read More
TRC-093 shows promise in phase I trial in patients with solid tumors
Read More
ViroPharma files PAS with FDA for Cinryze
Read More
Dyax and Sigma-Tau partner on DX-88 for HAE and other indications
Read More
OMJPI and Diamyd join to develop diabetes therapy rhGAD65
Read More
Mologen provides update on clinical status of MGN-1601 and MGN-1703
Read More
Pfizer withdraws Mylotarg from U.S. market due to safety concerns
Read More
Neurologix phase II trial shows efficacy of NLX-P101 in PD
Read More
MJFF provides funds for Ceregene's phase II CERE-120 trial
Read More
Nereus completes enrollment in phase II plinabulin trial in lung cancer
Read More
Novo Nordisk restarts phase III development of liraglutide for obesity
Read More
Takeda announces U.S. launch of ACTOplus met XR
Read More
FDA approves Lucentis for macular edema following retinal vein occlusion
Read More
QLT reports on Visudyne-Lucentis combination in wet AMD
Read More
Medivir and GSK to market Xerclear for treatment of cold sores
Read More
GSK and Prosensa expand development of DMD treatments
Read More
Tolera's TOL-101 receives orphan drug status for type 1 diabetes
Read More
